[Spironolactone in essential hypertension associated with abnormal aldosterone regulation and in Conn's syndrome (author's transl)].
D000236:Adenoma / Q000188:drug therapy; D000310:Adrenal Gland Neoplasms / Q000188:drug therapy; D000328:Adult; D000450:Aldosterone / Q000652:urine; D005260:Female; D006801:Humans; D006929:Hyperaldosteronism / Q000188:drug therapy*; D006973:Hypertension / Q000188:drug therapy* / Q000652:urine; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000097:blood; D013148:Spironolactone / Q000627:therapeutic use*
D013148:Spironolactone; D000450:Aldosterone; D011188:Potassium
Spironolacton bei essentieller Hypertonie mit gestörter Aldosteron-Regulation und bei Conn-Syndrom.